In line with our findings, the use of anti-VEGF-A therapeutic antibodies has already shown promising results in several other animal models of rheumatic disorders, including osteoarthritis and collagen-induced arthritis [31–34]. This evidence concerns the gene VEGFA and osteoarthritis.